Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients
Condition(s):Peripheral T-cell LymphomaLast Updated:August 27, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Peripheral T-cell LymphomaLast Updated:August 27, 2012Terminated
Condition(s):Recurrent or Metastatic Head and Neck CarcinomaLast Updated:March 5, 2019Completed
Condition(s):Multiple MyelomaLast Updated:May 8, 2014Completed
Condition(s):Pancreatic NeoplasmsLast Updated:August 18, 2016Unknown status
Condition(s):Intraventricular NeoplasmLast Updated:February 8, 2023Completed
Condition(s):Colon NeoplasmLast Updated:May 21, 2019Completed
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Gene RearrangementsLast Updated:January 9, 2024Active, not recruiting
Condition(s):CancerLast Updated:September 17, 2013Completed
Condition(s):Healthy VolunteersLast Updated:March 23, 2023Recruiting
Condition(s):Thyroid NeoplasmLast Updated:April 21, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.